NCT00696826View on ClinicalTrials.gov

A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
Liver Insufficiency
Interventions
DRUG

sitagliptin phosphate

sitagliptin phosphate 100 mg MK0431 (2 x 50 mg tablets) taken orally after overnight fast; Duration of Treatment: 5 Weeks

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00696826 - A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED) | Biotech Hunter | Biotech Hunter